(Tiper Stock Exchange) – Catalenta US company specializing in pharmaceutical outsourcing services, has added four new members to its board of directors and announced it will lead a strategic review of the business after reaching a agreement with activist investor Elliott Investment Management.
In particular, the board approved the appointment of four new independent directors: Steven Barg, Frank D’Amelio, Stephanie Okey and Michelle Ryan. With these appointments, Catalent’s board will consist of 16 directors, 13 of whom are independent.
In addition, John Greisch has been named executive chairman and will also chair the new strategic and operational review board. This is the new body that will conduct a review of the company’s business, strategy and operations, as well as capital allocation priorities, with a view to maximizing long-term value.
(Photo: Benjamin Child on Unsplash)